Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testing procedures for HbA1c quantitation.
Published December 19, 2018 · Recall initiated: October 5, 2018
Summary
FDA records medical device Class III recall Z-0601-2019, published December 19, 2018 and initiated October 5, 2018. Recalling firm: Tosoh Bioscience Inc; Status: Terminated; Reported quantity: 1000; Lot: Lot 7055. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If degradation of these controls occurs, P00 peaks may be seen and the % HbA1c control values may drift higher than the assigned range. This may result in delays when performing routine instrument quality control. If this issue occurs, there may be a delay in testing and reporting patient test results. Tosoh has received two (2) complaints related to this issue with no serious injuries reported.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Tosoh Bioscience Inc
- Distributor
- Distributed nationwide. Foreign distribution to Canada.
- Lot
- Lot 7055
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone inJuly 22, 2026
- FDATosoh Bioscience AIA-PACK BHCG Calibration Verification Test Set-In Vitro Diagnostic for BHCG-pregnancy PartSeptember 23, 2020
- FDAST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for theJanuary 2, 2019
- FDAAIA-PACK Folate (FOL) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of folateJanuary 2, 2019
- FDAOrthopedic Salvage System (OSS) Porous Stem, Item No. 150394December 19, 2018
- FDABinding Site Human IgM Kit (for SPAPLUS), REF: NK012.S The device consists of reaction buffer, sheep anti-IgMDecember 19, 2018
Questions about this recall
Was Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testing procedures for HbA1c quantitation. recalled?
Yes. FDA published recall Z-0601-2019 on December 19, 2018. Reported hazard: Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If degradation of these controls occurs, P00 peaks may be seen and the % HbA1c control values may drift higher than the assigned range. This may result in delays when performing routine instrument quality control. If this issue occurs, there may be a delay in testing and reporting patient test results. Tosoh has received two (2) complaints related to this issue with no serious injuries reported.
What should I do if I have this product?
Voluntary: Firm initiated · Letter